A meta-analysis suggests allogeneic stem cell transplantation (allo-SCT) should not be recommended following first-line ...

Defining "value" in cancer care goes beyond survival and should encompass patient quality of life metrics, said Coral Omene, MD, PhD, of Robert Wood Johnson Medical School.

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

The Congressional Budget Office estimates the package would add $2.4 trillion to the national deficit over a decade and leave ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

Tariff increases threaten the US economy and health care costs, impacting managed care affordability and member financial ...

TP53 aberrations and circulating tumor DNA burden were found to be predictors of poor outcomes in high-risk patients with ...

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

To truly shift the landscape in obesity care, explains Jaime Almandoz, MD, MBA, UT Southwestern, care models and policies ...

The findings provide insight into which patients may have favorable or inferior responses to immunotherapy for small cell ...

Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations ...